Chemomab Therapeutics LTD Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Neil Harris Cohen, a Director of Chemomab Therapeutics Ltd., sold 2,304 shares of common stock on August 27, 2026.
NASDAQ
Chemomab Therapeutics CEO Adi Mor George reports transactions involving American Depositary Shares and Restricted Share Units.